Open Access
RESIDENT’S CORNER
Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasis
1
Temple University Hospital, Philadelphia, Pennsylvania, USA
2 University of Mississippi Medical Center, Jackson, Mississippi, USA
3
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Address correspondence to Dr. S.M. Norberg, Temple University
Hospital, 3401 N Broad Street, Philadelphia, PA 19140 USA
Canadian Journal of Urology 2015, 22(2), 7755-7757.
Abstract
Cutaneous metastases from urologic cancers are very uncommon, usually represent widespread metastatic disease and are associated with a very poor prognosis. They may occur in 1% of patients with urologic malignancies, most commonly from kidney, followed by bladder and prostate tumors. In this report, we describe a case of urothelial carcinoma with metastases to the scrotum treated with platinum based chemotherapy with a durable complete response lasting more than 14 months. Molecular profiling revealed deleterious mutations in e-cadherin and retinoblastoma genes, suggesting their possible role in the pathogenesis of cutaneous metastases. Further studies are needed to validate this observation.Keywords
Cite This Article

This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.